Corporate Profile
WuXi PharmaTech (pronounced woo-shee pharma-tek) is a leading global contract R&D services provider serving the pharmaceutical, biotech, and medical device industries. The company is headquartered in Shanghai and has operations in both China and the United States. We provide a broad and integrated portfolio of laboratory and manufacturing services throughout the R&D process. Our services are designed to help our global partners shorten the time and lower the cost of R&D. The parent company is known as WuXi PharmaTech, and its operating divisions are known as WuXi AppTec (pronounced woo-shee app-tek)... More >>
What's New
download pdf  Investor Fact Sheet
Recent NewsMore >>
10/06/15Sidra Selects WuXi NextCODE to Power Population Genomics and Precision Medicine in Qatar
Printer Friendly Version
09/17/15WuXi PharmaTech Receives 2015 Open-Access R&D Technology Leadership Award from Frost & Sullivan
SHANGHAI, Sept. 17, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, today announced that it has been awarded the 2015 Frost & Sullivan North American Open-Access R&D Technology Leadership Award. The award is part of Frost & Sullivan's Growth, Innovation & Leadership Award series, recognizing companies that have demonstra... 
Printer Friendly Version
09/16/15WuXi NextCODE and Fudan Children’s Hospital Partner to Lead Whole Genome Diagnostics for Rare Diseases in China
Printer Friendly Version
08/27/15WuXi PharmaTech's STA Subsidiary Receives First Approval from Japanese Regulatory Authorities
SHANGHAI, Aug. 27, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, today announced that its small-molecule process development and manufacturing subsidiary Shanghai SynTheAll Pharmaceutical Co., Ltd. (STA) received its first approval from the Japan PMDA for the manufacture of the GMP intermediate of a branded commercial drug in July. ST... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Stock QuoteMore >>
WX (Common Stock)
ExchangeNYSE (US Dollar)
Change (%) Stock is Up 0.57 (1.32%)
Data as of 10/06/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
CalendarMore >>
October 2015?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
52 Week High
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever WuXi PharmaTech (Cayman) Inc. posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.